文献速递脑血管病

他汀强度与依从性对急性缺血性卒中远期预后的影响

Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2017-09-15

该回顾性队列研究利用韩国全国医保理赔数据,纳入2002至2012年急性缺血性卒中住院患者8001例,根据卒中后1年处方数据判定他汀依从性与强度。主要结局为复发性卒中、心肌梗死与全因死亡的复合终点。结果显示,与未用他汀者相比,良好依从者调整后风险比0.74(95%CI 0.64-0.84),且良好依从者中高强度他汀较代强度他汀风险更低(aHR 0.48,95%CI 0.24-0.96)。

要点

  • 急性缺血性卒中后良好依从他汀与复合不良结局风险降低相关(aHR 0.74)。
  • 良好依从者中高强度他汀较代强度他汀不良事件风险更低(aHR 0.48)。
  • 良好依从或高强度他汀均未增加出血性卒中风险。

核心结论

  • 急性缺血性卒中后,高强度他汀治疗且良好依从与较低的不良事件风险显著相关。

研究设计与样本

  • 回顾性队列研究,使用韩国全国医保理赔数据,纳入2002至2012年急性缺血性卒中住院患者8001例。
  • 他汀依从性与强度根据卒中后1年处方数据判定,主要结局为复发性卒中、心肌梗死与全因死亡的复合终点,采用多因素Cox比例回归分析。

主要发现

  • 平均随访4.69±2.72年期间,2284例患者发生主要结局。
  • 与未用他汀者相比,良好依从者调整后风险比为0.74(95%CI 0.64-0.84),中等依从者为0.93(95%CI 0.79-1.09),差依从者为1.07(95%CI 0.95-1.20)。
  • 在1712例良好依从患者中,高强度他汀较代强度他汀的不良事件风险更低(调整后风险比0.48,95%CI 0.24-0.96)。
  • 良好依从或高强度他汀均与出血性卒中风险增加无关。

临床怎么用

  • 对急性缺血性卒中患者,应优先选择高强度他汀并强调良好依从性以改善长期预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Statin is an established treatment for secondary prevention after ischemic stroke. However, the effects of statin intensity and adherence on the long-term prognosis after acute stroke are not well known. METHODS: This retrospective cohort study using a nationwide health insurance claim data in South Korea included patients admitted with acute ischemic stroke between 2002 and 2012. Statin adherence and intensity were determined from the prescription data for a period of 1 year after the index stroke. The primary outcome was a composite of recurrent stroke, myocardial infarction, and all-cause mortality. We performed multivariate Cox proportional regression analyses. RESULTS: We included 8001 patients with acute ischemic stroke. During the mean follow-up period of 4.69±2.72 years, 2284 patients developed a primary outcome. Compared with patients with no statin, adjusted hazard ratios (95% confidence interval) were 0.74 (0.64-0.84) for good adherence, 0.93 (0.79-1.09) for intermediate adherence, and 1.07 (0.95-1.20) for poor adherence to statin. Among the 1712 patients with good adherence, risk of adverse events was lower in patients with high-intensity statin (adjusted hazard ratio [95% confidence interval], 0.48 [0.24-0.96]) compared with those with low-intensity statin. Neither good adherence nor high intensity of statin was associated with an increased risk of hemorrhagic stroke. CONCLUSIONS: After acute ischemic stroke, high-intensity statin therapy with good adherence was significantly associated with a lower risk of adverse events.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kim J, Lee HS, Nam CM, et al. Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke. Stroke. 2017. PMID: 28916672. doi:10.1161/STROKEAHA.117.018140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。